# TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System

Study · id `cardio:ct-nct07798726` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07798726](<https://clinicaltrials.gov/study/NCT07798726>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT07798726

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 565 participants.

## Technical summary

Registry record NCT07798726. Non-randomized; no masking; primary purpose treatment. Start 2026-10-21 (actual); primary completion 2031-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; non-randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 565 participants (planned count; ClinicalTrials.gov record NCT07798726, source copy `cardio:ctgov-nct07798726-2026-11-13`, retrieved 2026-11-18)
- Started: 2026-10-21 (actual) (ClinicalTrials.gov record NCT07798726, source copy `cardio:ctgov-nct07798726-2026-11-13`, retrieved 2026-11-18)
- Primary completion: 2031-12-31 (anticipated) (ClinicalTrials.gov record NCT07798726, source copy `cardio:ctgov-nct07798726-2026-11-13`, retrieved 2026-11-18)
- Completion: 2035-12-31 (anticipated) (ClinicalTrials.gov record NCT07798726, source copy `cardio:ctgov-nct07798726-2026-11-13`, retrieved 2026-11-18)
- Countries: United States (ClinicalTrials.gov record NCT07798726, source copy `cardio:ctgov-nct07798726-2026-11-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07798726-2026-11-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: TransCatheter Replacement Of the Mitral Valve With the Novel Cephea Mitral Valve System
- Acronym: CROWN-MV
- Condition: Mitral Valve Disease
- Condition: Mitral Annulus Calcification
- Condition: Mitral Regurgitation
- Condition: Mitral Stenosis
- Condition: Mitral Valve (MV) Regurgitation
- Condition: Mitral Valve Replacement
- Condition: Transcatheter Valve Replacement
- Condition: Mitral Valve Insufficiency
- Condition: Heart Valve Disease
- Intervention (Device): Cephea Mitral Valve System
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry condition terms include this condition: Mitral stenosis (`cardio:mitral-stenosis`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: bdfcfde3b451f95d17a310cd050a74a21fb80fa31057b432578c41667046bda0
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
